Ingalls & Snyder LLC Durect Corp Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	BUY	$0.43 - $5.9 $25,800 - $354,000	60,000 Added 0.66%	9,124,505 $5.28 Million
Q2 2022 Aug 11, 2022	BUY	$0.38 - $0.64 $692,025 - $1.17 Million	1,821,120 Added 25.14%	9,064,505 $4.33 Million
Q1 2022 May 09, 2022	SELL	$0.55 - $0.98 $32,158 - $57,300	-58,470 Reduced 0.8%	7,243,385 $4.85 Million
Q4 2021 Feb 11, 2022	BUY	$0.9 - $1.31 $2,610 - $3,799	2,900 Added 0.04%	7,301,855 $7.2 Million
Q3 2021 Oct 27, 2021	SELL	$1.21 - $1.61 $143,808 - $191,348	-118,850 Reduced 1.6%	7,298,955 $9.34 Million
Q2 2021 Aug 03, 2021	SELL	$1.6 - $2.02 $1,600 - $2,020	-1,000 Reduced 0.01%	7,417,805 $12.1 Million
Q1 2021 Apr 21, 2021	BUY	$1.86 - $2.87 $98,487 - $151,966	52,950 Added 0.72%	7,418,805 $14.7 Million
Q4 2020 Jan 27, 2021	SELL	$1.65 - $2.43 $256,670 - $378,005	-155,558 Reduced 2.07%	7,365,855 $15.2 Million
Q3 2020 Oct 21, 2020	SELL	$1.6 - $2.35 $426,947 - $627,078	-266,842 Reduced 3.43%	7,521,413 $12.9 Million
Q2 2020 Jul 31, 2020	SELL	$1.33 - $2.76 $17,423 - $36,156	-13,100 Reduced 0.17%	7,788,255 $18.1 Million
Q1 2020 Apr 22, 2020	SELL	$0.97 - $2.85 $4,268 - $12,540	-4,400 Reduced 0.06%	7,801,355 $12.1 Million
Q4 2019 Jan 15, 2020	SELL	$1.69 - $3.8 $650,312 - $1.46 Million	-384,800 Reduced 4.7%	7,805,755 $29.7 Million
Q3 2019 Oct 16, 2019	SELL	$0.61 - $2.21 $31,049 - $112,489	-50,900 Reduced 0.62%	8,190,555 $15.1 Million
Q2 2019 Jul 11, 2019	SELL	$0.51 - $0.86 $3,441 - $5,804	-6,749 Reduced 0.08%	8,241,455 $5.37 Million
Q1 2019 Apr 11, 2019	SELL	$0.51 - $0.82 $109,650 - $176,300	-215,000 Reduced 2.54%	8,248,204 $5.16 Million
Q4 2018 Jan 24, 2019	SELL	$0.48 - $1.1 $122,736 - $281,270	-255,700 Reduced 2.93%	8,463,204 $4.09 Million
Q3 2018 Oct 24, 2018	BUY	$1.06 - $1.69 $74,942 - $119,483	70,700 Added 0.82%	8,718,904 $9.59 Million
Q1 2018 Apr 17, 2018	BUY	$0.91 - $2.24 $42,770 - $105,280	47,000 Added 0.55%	8,648,204 $18.5 Million
Q4 2017 Jan 19, 2018	BUY	$0.78 - $2.1 $1.7 Million - $4.57 Million	2,174,122 Added 33.83%	8,601,204 $7.93 Million
Q3 2017 Oct 20, 2017	BUY	$1.55 - $1.82 $9.96 Million - $11.7 Million	6,427,082	6,427,082 $11.4 Million

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account